Moreover, the large analysis of Surveillance, Epidemiology, and End Results database revealed that 44% of low risk prostate cancer defined as cT1c/2a, ISUP 1, and PSA below 10 ng/mL was upgraded at final pathological report [14]. The gene discussed is KLK3; the disease is prostate cancer.